JP2015533511A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015533511A5 JP2015533511A5 JP2015541130A JP2015541130A JP2015533511A5 JP 2015533511 A5 JP2015533511 A5 JP 2015533511A5 JP 2015541130 A JP2015541130 A JP 2015541130A JP 2015541130 A JP2015541130 A JP 2015541130A JP 2015533511 A5 JP2015533511 A5 JP 2015533511A5
- Authority
- JP
- Japan
- Prior art keywords
- gram
- negative bacterium
- pneumoniae
- gene
- coli
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261723408P | 2012-11-07 | 2012-11-07 | |
| US61/723,408 | 2012-11-07 | ||
| PCT/EP2013/073266 WO2014072405A1 (en) | 2012-11-07 | 2013-11-07 | Production of recombinant vaccine in e. coli by enzymatic conjugation |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018186302A Division JP6833785B2 (ja) | 2012-11-07 | 2018-10-01 | 酵素的コンジュゲート化による大腸菌での組み換えワクチンの製造 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015533511A JP2015533511A (ja) | 2015-11-26 |
| JP2015533511A5 true JP2015533511A5 (enExample) | 2016-12-22 |
| JP6412875B2 JP6412875B2 (ja) | 2018-10-24 |
Family
ID=49552366
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015541130A Expired - Fee Related JP6412875B2 (ja) | 2012-11-07 | 2013-11-07 | 酵素的コンジュゲート化による大腸菌での組み換えワクチンの製造 |
| JP2018186302A Expired - Fee Related JP6833785B2 (ja) | 2012-11-07 | 2018-10-01 | 酵素的コンジュゲート化による大腸菌での組み換えワクチンの製造 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018186302A Expired - Fee Related JP6833785B2 (ja) | 2012-11-07 | 2018-10-01 | 酵素的コンジュゲート化による大腸菌での組み換えワクチンの製造 |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US20150273043A1 (enExample) |
| EP (3) | EP2917351B1 (enExample) |
| JP (2) | JP6412875B2 (enExample) |
| KR (1) | KR20150079964A (enExample) |
| CN (1) | CN105008539B (enExample) |
| AU (2) | AU2013343520B2 (enExample) |
| BR (1) | BR112015010283A8 (enExample) |
| CA (2) | CA2889767C (enExample) |
| EA (1) | EA201590705A1 (enExample) |
| ES (3) | ES2882282T3 (enExample) |
| IL (1) | IL238586A0 (enExample) |
| MX (1) | MX366912B (enExample) |
| SG (1) | SG11201503308XA (enExample) |
| TR (1) | TR201903066T4 (enExample) |
| WO (1) | WO2014072405A1 (enExample) |
| ZA (1) | ZA201503097B (enExample) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NO2501406T3 (enExample) * | 2009-11-19 | 2018-05-19 | ||
| BR112016007727A8 (pt) * | 2013-10-11 | 2018-01-30 | Glycovaxyn Ag | célula hospedeira, e, método para produzir uma proteína n-glicosilada. |
| NZ723328A (en) | 2014-02-24 | 2018-01-26 | Glycovaxyn Ag | Compositions comprising e. coli o25b antigen, uses thereof and methods of manufacture |
| MX378857B (es) * | 2014-04-17 | 2025-03-10 | Glaxosmithkline Biologicals Sa | Celulas huespedes modificadas y usos de las mismas. |
| AR104469A1 (es) | 2014-08-08 | 2017-07-26 | Glycovaxyn Ag | Células huésped modificadas para su uso en producción de bioconjugados |
| US10265391B2 (en) * | 2015-02-26 | 2019-04-23 | Vaxnewmo Llc | Acinetobacter O-oligosaccharyltransferases and uses thereof |
| GB201518668D0 (en) * | 2015-10-21 | 2015-12-02 | Glaxosmithkline Biolog Sa | Immunogenic Comosition |
| GB201610599D0 (en) | 2016-06-17 | 2016-08-03 | Glaxosmithkline Biologicals Sa | Immunogenic Composition |
| CN105963691B (zh) * | 2016-07-03 | 2020-05-01 | 查文娟 | 一种肺炎链球菌疫苗 |
| CN106929573B (zh) * | 2017-02-21 | 2020-06-09 | 南开大学 | 对嗜肺军团菌O12型的wzm和wecA基因特异的核苷酸序列及其应用 |
| GB201711635D0 (en) | 2017-07-19 | 2017-08-30 | Glaxosmithkline Biologicals Sa | Immunogenic composition |
| GB201712678D0 (en) | 2017-08-07 | 2017-09-20 | Glaxosmithkline Biologicals Sa | Process for the manipulation of nucleic acids |
| WO2019043245A1 (en) * | 2017-09-04 | 2019-03-07 | London School Of Hygiene And Tropical Medicine | MICROBIAL CELLS EXPRESSING STREPTOCOCCAL SERROTYPES |
| US11235046B2 (en) | 2017-11-04 | 2022-02-01 | Nevada Research & Innovation Corporation | Immunogenic conjugates and methods of use thereof |
| GB201721582D0 (en) | 2017-12-21 | 2018-02-07 | Glaxosmithkline Biologicals Sa | S aureus antigens and immunogenic compositions |
| GB201721576D0 (en) | 2017-12-21 | 2018-02-07 | Glaxosmithkline Biologicals Sa | Hla antigens and glycoconjugates thereof |
| ES3051337T3 (en) | 2018-06-16 | 2025-12-26 | Vaxnewmo Llc | Glycosylated comp pilin variants, methods of making and uses thereof |
| US11260119B2 (en) | 2018-08-24 | 2022-03-01 | Pfizer Inc. | Escherichia coli compositions and methods thereof |
| EP3650044A1 (en) * | 2018-11-06 | 2020-05-13 | ETH Zürich | Anti-glycan vaccines |
| US12350342B2 (en) | 2018-12-21 | 2025-07-08 | Vaxnewmo Llc | O-linked glycosylation recognition motifs |
| IL286467B2 (en) | 2019-03-18 | 2026-02-01 | Janssen Pharmaceuticals Inc | Methods for producing bioconjugates of polysaccharides E. coli o-antigen, preparations thereof and methods for using them |
| EP3770269A1 (en) | 2019-07-23 | 2021-01-27 | GlaxoSmithKline Biologicals S.A. | Quantification of bioconjugate glycosylation |
| CN112369722B (zh) * | 2020-05-08 | 2023-03-17 | 湖北中烟工业有限责任公司 | 加热不燃烧装置和温度控制方法 |
| CN111518738B (zh) | 2020-05-08 | 2022-02-08 | 徐州海润生物科技有限公司 | 重组卡介苗及其制备方法和应用 |
| CA3185719A1 (en) * | 2020-06-18 | 2021-12-23 | Glaxosmithkline Biologicals Sa | Shigella-tetravalent (shigella4v) bioconjugate |
| US20230226175A1 (en) | 2020-06-25 | 2023-07-20 | Glaxosmithkline Biologicals Sa | Modified exotoxin a proteins |
| PE20231385A1 (es) | 2020-09-17 | 2023-09-12 | Janssen Pharmaceuticals Inc | Composiciones de vacunas multivalentes y usos de las mismas |
| US12138302B2 (en) | 2020-10-27 | 2024-11-12 | Pfizer Inc. | Escherichia coli compositions and methods thereof |
| US12357681B2 (en) | 2020-12-23 | 2025-07-15 | Pfizer Inc. | E. coli FimH mutants and uses thereof |
| EP4452308A1 (en) | 2021-12-22 | 2024-10-30 | GlaxoSmithKline Biologicals S.A. | Vaccine |
| GB202302579D0 (en) | 2023-02-23 | 2023-04-12 | Glaxosmithkline Biologicals Sa | Immunogenic composition |
| WO2025172892A1 (en) | 2024-02-16 | 2025-08-21 | Glaxosmithkline Biologicals Sa | Modified proteins and methods |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2638595A (en) * | 1994-05-16 | 1995-12-05 | Uab Research Foundation, The | (streptococcus pneumoniae) capsular polysaccharide genes and flanking regions |
| US7018637B2 (en) * | 1998-02-23 | 2006-03-28 | Aventis Pasteur, Inc | Multi-oligosaccharide glycoconjugate bacterial meningitis vaccines |
| US7541043B2 (en) | 2002-01-16 | 2009-06-02 | The United States Of America As Represented By The Department Of Health And Human Services | Vaccine for protection against Shigella sonnei disease |
| DK1481057T3 (da) | 2002-03-07 | 2006-05-15 | Eidgenoess Tech Hochschule | System og fremgangsmåde til fremstilling af rekombinante glycosylerede proteiner i en prokaryot vært |
| ES2535084T3 (es) | 2005-05-11 | 2015-05-05 | Eth Zurich | Proteínas N-glicosiladas recombinantes procedentes de células procariotas |
| SI2257307T1 (sl) | 2008-02-20 | 2018-09-28 | Glaxosmithkline Biologicals S.A. | Biokonjugati, izdelani iz rekombinantnih N-glikoziliranih proteinov iz prokariontskih celic |
| WO2010110931A2 (en) | 2009-03-23 | 2010-09-30 | The Brigham And Women's Hospital, Inc. | Glycoconjugate vaccines |
| JP2012533285A (ja) | 2009-07-17 | 2012-12-27 | オーシャン ハーベスト テクノロジー （カナダ） インコーポレイテッド | 魚用飼料中の合成添加物を置換する、天然かつ持続可能な海藻配合物 |
| WO2011138361A1 (en) | 2010-05-06 | 2011-11-10 | Glycovaxyn | Capsular gram-positive bacteria bioconjugate vaccines |
| KR20150068998A (ko) * | 2012-10-12 | 2015-06-22 | 글리코박신 아게 | 숙주 세포 변형 방법 |
-
2013
- 2013-11-07 EP EP13788753.5A patent/EP2917351B1/en active Active
- 2013-11-07 BR BR112015010283A patent/BR112015010283A8/pt not_active Application Discontinuation
- 2013-11-07 JP JP2015541130A patent/JP6412875B2/ja not_active Expired - Fee Related
- 2013-11-07 KR KR1020157014830A patent/KR20150079964A/ko not_active Withdrawn
- 2013-11-07 CA CA2889767A patent/CA2889767C/en active Active
- 2013-11-07 EP EP18198665.4A patent/EP3444352B1/en active Active
- 2013-11-07 MX MX2015005797A patent/MX366912B/es active IP Right Grant
- 2013-11-07 WO PCT/EP2013/073266 patent/WO2014072405A1/en not_active Ceased
- 2013-11-07 EA EA201590705A patent/EA201590705A1/ru unknown
- 2013-11-07 CA CA3125293A patent/CA3125293A1/en active Pending
- 2013-11-07 ES ES18211761T patent/ES2882282T3/es active Active
- 2013-11-07 ES ES13788753T patent/ES2713166T3/es active Active
- 2013-11-07 SG SG11201503308XA patent/SG11201503308XA/en unknown
- 2013-11-07 EP EP18211761.4A patent/EP3508579B1/en active Active
- 2013-11-07 US US14/440,311 patent/US20150273043A1/en not_active Abandoned
- 2013-11-07 ES ES18198665T patent/ES2848774T3/es active Active
- 2013-11-07 CN CN201380069524.XA patent/CN105008539B/zh not_active Expired - Fee Related
- 2013-11-07 TR TR2019/03066T patent/TR201903066T4/tr unknown
- 2013-11-07 AU AU2013343520A patent/AU2013343520B2/en not_active Ceased
-
2015
- 2015-05-03 IL IL238586A patent/IL238586A0/en unknown
- 2015-05-06 ZA ZA2015/03097A patent/ZA201503097B/en unknown
-
2017
- 2017-12-20 AU AU2017279688A patent/AU2017279688B2/en not_active Ceased
-
2018
- 2018-07-13 US US16/034,906 patent/US10973901B2/en not_active Expired - Fee Related
- 2018-10-01 JP JP2018186302A patent/JP6833785B2/ja not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2017279688B2 (en) | Production of recombinant vaccine in e. coli by enzymatic conjugation | |
| HRP20240847T1 (hr) | Novi polisaharid i njegove upotrebe | |
| Wen et al. | Bacterial capsules | |
| JP6682451B2 (ja) | 改変型宿主細胞およびその使用 | |
| JP2017036303A5 (enExample) | ||
| US11596677B2 (en) | Induction of protective immunity against antigens | |
| BR112014018815B1 (pt) | Composição imunogênica compreendendo conjugado proteína-polissacarídeo x de n. meningitidis | |
| CN104902931A (zh) | 包含修饰的抗原的生物缀合物及其用途 | |
| CN104487086B (zh) | 无动物源的不含酒精的疫苗组合物及其制备方法 | |
| US10716839B2 (en) | Compositions and methods for producing bacterial conjugate vaccines | |
| JP7699543B2 (ja) | Ｏ結合型グリコシル化認識モチーフ | |
| Baliban et al. | Immunogenicity and efficacy following sequential parenterally-administered doses of Salmonella Enteritidis COPS: FliC glycoconjugates in infant and adult mice | |
| CN110462020A (zh) | 针对抗原的保护性免疫的诱导 | |
| WO2006065137A2 (en) | Novel efficient production process for capsular polysaccharides of pathogenic grampositive bacteria by heterologous expression and secretion of complex polysaccharides in non-pathogenic, non-invasive gram- positive bacteria | |
| CN106110316A (zh) | 一种肺炎球菌结合物组合疫苗的制备方法 | |
| Schuster et al. | Immunogenicity and protective efficacy against Salmonella C2-C3 infection in mice immunized with a glycoconjugate of S. Newport Core-O polysaccharide linked to the homologous serovar FliC protein | |
| ES2933027T3 (es) | Purificación de polisacáridos secretados de S. agalactiae | |
| JP5547657B2 (ja) | パスツレラ・ムルトシダ（Ｐ．ｍｕｌｔｏｃｉｄａ）のｆｕｒ細胞およびその外膜タンパク質の抽出物によるパスツレラ・ムルトシダ（Ｐａｓｔｅｕｒｅｌｌａｍｕｌｔｏｃｉｄａ）に対する異種性の防御 | |
| CN115362177A (zh) | 糖类的纯化 | |
| Chan et al. | The new first-line defense: the potential of nasopharyngeal colonization in vaccine strategies | |
| Hosny et al. | Immune response to Vi polysaccharide, heat-killed whole cells, and outer membrane protein of Salmonella typhi | |
| MacLennan et al. | New Approaches for Needed Vaccines: Bacteria | |
| BR122024027321A2 (pt) | Composições imunogênicas de vacina | |
| HK40076438A (en) | Purification of saccharides | |
| RU2601158C1 (ru) | ШТАММЫ ВИДА Streptococcus pneumoniae (ВАРИАНТЫ) И СПОСОБ ПОЛУЧЕНИЯ ИЗ НИХ ПРОТЕКТИВНОЙ БЕЛОКСОДЕРЖАЩЕЙ ФРАКЦИИ, ОБЛАДАЮЩЕЙ ВНУТРИВИДОВОЙ ИММУНОГЕННОЙ АКТИВНОСТЬЮ |